Besides, Ctr9 KD also decreased RNAPII occupancy at 1583 non-E2-responsive genes (Fig. 3f), suggesting that Ctr9-dependent RNAPII chromatin occupancy is not restricted to the estrogen regulated genes in breast cancer. This evidence concerns the gene CTR9 and breast carcinoma.